This study was supported by the National Natural Science Foundation of China(grant numbers:31972644,32272959);the University Synergy Innovation Program of Anhui Province(grant number:GXXT-2019-035);the Jiangsu Provincial Medical Innovation Team(grant number:CXTDA2017024);the leading technology foundation research project of Jiangsu Province(grant number:BK20192005).
Background:The chicken chorioallantoic membrane(CAM)model is a potential alter-native to the mouse model based on the 3R principles.However,its value for deter-mination of the in vivo behaviors of radiolabeled peptide...
supported by the National Natural Science Foundation of China(NOs.22201178,and 32071414);the National Key Research and Development Program of China(No.2020YFA0907702).
Proteolysis targeting chimeras (PROTACs) have recently emerged as promising therapeutic agents for cancer therapy. However, their clinical application is considerably hindered by the poor membrane permeability and ins...
supported by the National Key Research and Development Plan of China(No.2020YFA0907702);the National Facility for Translational Medicine(Shanghai)(No.TMST-2020-001).
Affibody is a new class of small non-immunoglobulin affinity proteins that possesses high affinity at the picomole level to several tumor overexpressed receptors.Owing to the simple framework,affibody is flexible for ...
supported by the National Natural Science Foundation of China(81421004,81301268);Beijing Nova Program Interdisciplinary Cooperation Project (xxjc201812);International S&T Cooperation Program of China(2015DFA30440);Beijing Nova Program(Z131107000413063);CAMS Innovation Fund for Medical Sciences(CIFMS 2020-I2M-C&T-B-035)。
Follicular thyroid carcinoma(FTC)is the second most common form of thyroid malignancy,and it is associated with more aggressive growth and worse long-term survival outcomes relative to papillary thyroid carcinoma(PTC)...
Research and Development Plan of China(No.2016YFA0201500,2020YFA0907702);National Facility for Translational Medi-cine(Shanghai)(No.TMST-2020-001)for financial support.
Affibody molecules are small nonimmunoglobulin affinity proteins,which can precisely target to some cancer cells with specific overexpressed molecular signatures.However,the relatively short in vivo half-life of them ...